Teduglutide for the treatment of short bowel syndrome - a safety evaluation

Expert Opinion on Drug Safety
Bharati Kochar, Hans H Herfarth

Abstract

Teduglutide is an analog of glucagon-like peptide 2 (GLP-2) which is approved for the treatment of patients with short bowel syndrome (SBS) who are dependent on parenteral support. Areas covered: Short bowel syndrome is a rare condition that can result from extensive resection of small bowel, congenital abnormalities, or inflammatory conditions that leads to poor nutrient processing capacity of the intestine. In this review, the safety reported in controlled clinical trials and real-world experience with teduglutide are presented in depth. Expert opinion: Trials and limited real-world experience demonstrated that teduglutide could decrease parenteral support requirements with the potential of achieving independence from parenteral support in some patients. This is an important treatment option for SBS patients given the well-established risks associated with parenteral support. The available data, albeit limited due to the small number of patients in the so-far performed studies, suggest that teduglutide appears to be safe to use in patients with intestinal failure who are dependent on parenteral support. However, additional long-term safety data are needed.

References

Feb 13, 2002·Gut·D J Drucker
Apr 3, 2003·Gastroenterology·Alan L BuchmanJon Fryer
Jan 25, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Stephen J D O'KeefeJonathan Shaffer
Feb 4, 2010·Seminars in Pediatric Surgery·Mark E McMellenBrad W Warner
Jan 22, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Stephen J D O'KeefeBernard Messing
Apr 9, 2013·Journal of Gastroenterology·Kazuhiro WatanabeMamoru Watanabe
Nov 20, 2013·JPEN. Journal of Parenteral and Enteral Nutrition·Darlene G KellyMarion F Winkler
Feb 4, 2014·JPEN. Journal of Parenteral and Enteral Nutrition·Palle B Jeppesen
Oct 15, 2014·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Loris PironiUNKNOWN Acute Intestinal Failure Special Interest Groups of ESPEN
Dec 20, 2014·Clinical and Experimental Gastroenterology·Kishore Vipperla, Stephen J O'Keefe
Jan 29, 2016·Inflammatory Bowel Diseases·Berkeley N LimketkaiJean-Frédéric Colombel
Feb 6, 2016·Clinical and Translational Gastroenterology·Lauren K SchwartzPalle B Jeppesen
Aug 11, 2016·JPEN. Journal of Parenteral and Enteral Nutrition·Ken FujiokaStéphane M Schneider
Jul 1, 2017·JPEN. Journal of Parenteral and Enteral Nutrition·Andrew UklejaAmareshwar Podugu
May 16, 2018·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Douglas L SeidnerThomas R Ziegler

❮ Previous
Next ❯

Citations

Feb 5, 2019·JPEN. Journal of Parenteral and Enteral Nutrition·Sharon CareyCherry Koh
Jan 24, 2019·Current Opinion in Pediatrics·A Adjowa Walker, Conrad R Cole
May 22, 2019·Clinical Case Reports·Joshua LeeDong Wook Kim
Jun 10, 2021·Expert Opinion on Drug Safety·Loris PironiAnna Simona Sasdelli
Aug 22, 2021·International Journal of Surgery Case Reports·Lukas SchlagerFelix Harpain

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.